$ACT News Icahn Enterprises reports profit up 14
Post# of 144499
Posted On: 03/06/2014 10:13:06 AM
$ACT News
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Forest Lab surges 27% premarket on Actavis deal 7:09 a.m. Feb. 18, 2014 - Silvia Ascarelli
Vansen Pharma Inc. appoints Ali Moghaddam to its Board of Advisors 8:30 a.m. Today - CNW Group
Teva Up on FDA Nod for Generic Evista - Analyst Blog 4:06 p.m. March 5, 2014 - Zacks.com
3 Stocks Pushing The Drugs Industry Downward 12:02 p.m. March 5, 2014 - TheStreet.com
Winning Stock Sectors for Tuesday, March 4 12:15 a.m. March 5, 2014 - WallStreetSectorSelector
Precious Metals, Health Care Led Mutual Funds In Feb. 5:21 p.m. March 4, 2014 - Investors Business Daily
Forest Labs Seeks Bystolic-Diovan Approval - Analyst Blog 5:20 p.m. March 4, 2014 - Zacks.com
Top Mutual Funds Add To Health Care, Leisure And Banks 5:20 p.m. March 4, 2014 - Investors Business Daily
Drugmakers Actavis, Biogen, Valeant Hold Near Highs 4:13 p.m. March 4, 2014 - Investors Business Daily
Pernix to Market Osmotica's Khedezla - Analyst Blog 5:30 p.m. March 3, 2014 - Zacks.com
Actavis Challenges Patents - Analyst Blog 4:45 p.m. March 3, 2014 - Zacks.com
Q4 Earnings Decline Y/Y at Endo, Weak Outlook - Analyst Blog 1:26 p.m. March 3, 2014 - Zacks.com
Biogen Idec Keeps Momentum Going With MS Drug Tecfidera 1:05 p.m. March 3, 2014 - Investors Business Daily
One Hardworking Bull 1:55 a.m. March 1, 2014 - Barrons.com
Actavis PLC (ACT): Today's Featured Health Care Laggard 5:01 p.m. Feb. 28, 2014 - TheStreet.com
Seattle Genetics Presents Data on Adcetris - Analyst Blog 3:17 p.m. Feb. 28, 2014 - Zacks.com
Patent Update from Mallinckrodt - Analyst Blog 5:20 p.m. Feb. 27, 2014 - Zacks.com
Valeant Beats Q4 Estimates, Talks Buyout Strategy 4:38 p.m. Feb. 27, 2014 - Investors Business Daily
Can The Uptrend Continue for Actavis (ACT)? - Tale of the Tape 9:47 a.m. Feb. 27, 2014 - Zacks.com
Enter Biosimilars: 3 Stock Picks - Analyst Blog 1:13 p.m. Feb. 26, 2014 - Zacks.com
Wider-than-Expected Loss at Pacira - Analyst Blog 12:20 p.m. Feb. 26, 2014 - Zacks.com
Actavis to Present at Barclays Global Healthcare Conference 8:00 a.m. March 4, 2014 - PR Newswire - PRF
Actavis Confirms Generic Colcrys® Patent Challenge 4:05 p.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Confirms Generic Multaq® Patent Challenge 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Forest Lab surges 27% premarket on Actavis deal 7:09 a.m. Feb. 18, 2014 - Silvia Ascarelli
Vansen Pharma Inc. appoints Ali Moghaddam to its Board of Advisors 8:30 a.m. Today - CNW Group
Teva Up on FDA Nod for Generic Evista - Analyst Blog 4:06 p.m. March 5, 2014 - Zacks.com
3 Stocks Pushing The Drugs Industry Downward 12:02 p.m. March 5, 2014 - TheStreet.com
Winning Stock Sectors for Tuesday, March 4 12:15 a.m. March 5, 2014 - WallStreetSectorSelector
Precious Metals, Health Care Led Mutual Funds In Feb. 5:21 p.m. March 4, 2014 - Investors Business Daily
Forest Labs Seeks Bystolic-Diovan Approval - Analyst Blog 5:20 p.m. March 4, 2014 - Zacks.com
Top Mutual Funds Add To Health Care, Leisure And Banks 5:20 p.m. March 4, 2014 - Investors Business Daily
Drugmakers Actavis, Biogen, Valeant Hold Near Highs 4:13 p.m. March 4, 2014 - Investors Business Daily
Pernix to Market Osmotica's Khedezla - Analyst Blog 5:30 p.m. March 3, 2014 - Zacks.com
Actavis Challenges Patents - Analyst Blog 4:45 p.m. March 3, 2014 - Zacks.com
Q4 Earnings Decline Y/Y at Endo, Weak Outlook - Analyst Blog 1:26 p.m. March 3, 2014 - Zacks.com
Biogen Idec Keeps Momentum Going With MS Drug Tecfidera 1:05 p.m. March 3, 2014 - Investors Business Daily
One Hardworking Bull 1:55 a.m. March 1, 2014 - Barrons.com
Actavis PLC (ACT): Today's Featured Health Care Laggard 5:01 p.m. Feb. 28, 2014 - TheStreet.com
Seattle Genetics Presents Data on Adcetris - Analyst Blog 3:17 p.m. Feb. 28, 2014 - Zacks.com
Patent Update from Mallinckrodt - Analyst Blog 5:20 p.m. Feb. 27, 2014 - Zacks.com
Valeant Beats Q4 Estimates, Talks Buyout Strategy 4:38 p.m. Feb. 27, 2014 - Investors Business Daily
Can The Uptrend Continue for Actavis (ACT)? - Tale of the Tape 9:47 a.m. Feb. 27, 2014 - Zacks.com
Enter Biosimilars: 3 Stock Picks - Analyst Blog 1:13 p.m. Feb. 26, 2014 - Zacks.com
Wider-than-Expected Loss at Pacira - Analyst Blog 12:20 p.m. Feb. 26, 2014 - Zacks.com
Actavis to Present at Barclays Global Healthcare Conference 8:00 a.m. March 4, 2014 - PR Newswire - PRF
Actavis Confirms Generic Colcrys® Patent Challenge 4:05 p.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Confirms Generic Multaq® Patent Challenge 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼